RecruitingNot ApplicableNCT06956300

TMS for Cognitive Decline in Aging and Preclinical AD

Grit Against Cognitive Decline in Aging and Preclinical Alzheimer's Disease


Sponsor

Massachusetts General Hospital

Enrollment

80 participants

Start Date

Apr 7, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

In this research study we want to learn more about the effects of non-invasive brain stimulation on motivation, memory, and brain-network function in cognitively unimpaired older adults and individuals with preclinical Alzheimer's disease. This study will use a form of non-invasive brain stimulation called repetitive Transcranial Magnetic Stimulation (rTMS). rTMS will slightly alter activity in an area of your brain that controls cognition. Changes resulting from this stimulation will be measured with behavioral tests, as well as by taking brain images with Magnetic Resonance Imaging (MRI). Participants will come in for one baseline visit followed by 10 days of daily rTMS study visits (Monday through Friday) and an evaluation visit. Then, there will be a 2-week break. After this break, they will return for another baseline visit, an additional 10 days of rTMS, and a final evaluation visit.


Eligibility

Min Age: 40 YearsMax Age: 99 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether transcranial magnetic stimulation (TMS) — a non-invasive brain stimulation technique using magnetic pulses applied to the scalp — can improve memory and thinking in older adults who are cognitively normal or in the very early stages of Alzheimer's disease (before symptoms appear). Researchers want to understand if TMS can slow cognitive decline. **You may be eligible if...** - You are between 40 and 99 years old - You are a native English speaker - You are cognitively normal or have been identified as having preclinical Alzheimer's disease (changes in the brain but no symptoms yet) - You are willing to undergo brain imaging (MRI) and memory testing at multiple time points **You may NOT be eligible if...** - You have had a serious head injury involving loss of consciousness - You have a major neurological or psychiatric condition - You have a known structural brain abnormality (such as a brain tumor or a past stroke) - You have any implant or metal in your body that is incompatible with MRI (e.g., a pacemaker, aneurysm clip, or cochlear implant) - You have a personal or family history (first-degree relative) of unprovoked seizures - You take medications that significantly lower the seizure threshold - You have a longstanding history (more than 10 years) of serious alcohol or substance abuse Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEActive rTMS

All study participants will receive one block of ACTIVE rTMS. Each block will consist of daily sessions of active rTMS delivered to the left dorsolateral prefrontal cortex over ten days (Monday through Friday).

DEVICESham rTMS

All study participants will receive one block of SHAM rTMS. Each block will consist of daily sessions of SHAM rTMS delivered to the left dorsolateral prefrontal cortex over ten days (Monday through Friday).


Locations(1)

Massachusetts General Hospital

Boston, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06956300


Related Trials